Table: begin end state 1 11 cytoplasmic 12 14 non-cytoplasmic 15 39 transmembrane 40 44 non-cytoplasmic 45 72 transmembrane 73 109 cytoplasmic 110 134 transmembrane 135 139 non-cytoplasmic 140 164 transmembrane 165 171 cytoplasmic 172 193 transmembrane 194 204 non-cytoplasmic 205 225 transmembrane 226 248 cytoplasmic 249 277 transmembrane 278 306 non-cytoplasmic 307 325 transmembrane 326 329 cytoplasmic 330 350 transmembrane 351 355 non-cytoplasmic 356 376 transmembrane 377 384 cytoplasmic 385 428 transmembrane 429 433 cytoplasmic 434 452 transmembrane 453 465 non-cytoplasmic 466 490 transmembrane 491 504 cytoplasmic
Input: >AO353_17570 MDTLNYLGQGFGVALTPYNLVTALCGTLIGTVVGLLPGLGPINGVALLIPIAFALGLPPE SALILLAAVYLGCEYGGRISSILLNIPGEASTVMTTLDGYPMARQGMAGVALSLSAWSSF IGAFIATCGMVLFAPLLAKWAIAFGPAEYFVLMVFAIVCLGGMAGDRPLKTFIAALIGLF LSCVGIDANSGVYRFTGDNIHLTDGIQFVVLVLGLFSISEILLLLEKTHHGQEAVKATGR MMFNFKEAASVFAVNIRCGVLGFIMGVLPGAGATLASAVAYMTEKRIAGASGTFGQGDKR GLAAPETAIGGAACGALVPMLTLGVPGSGTTAVMIGALSLYNITPGPLLFQQQPDIVWGL IASLFVANVMLVILNIPMIRIFTRILAVPNWALVPVIAIITGIGVYAVHATTFDLFLMIG IGIFGYILRKLDFPLSPVLLGFILGGLMEQNLRRALSISNGALEILWSSPITFGCWVLTA IMLLMPILRIWRKRSVARRAIADV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server